GO:0070303 negative regulation of stress-activated protein kinase signaling cascade: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070303 describes any process that stops, prevents, or reduces signaling through the stress-activated protein kinase (SAPK) cascade, which includes JNK and p38 MAPK pathways [1, 2, 4].
• Negative regulation of SAPK signaling is essential for preventing excessive inflammation, apoptosis, and growth arrest under stress conditions [3, 5, 7].
• Key negative regulators include MAPK phosphatases (MKPs), protein phosphatase 2C (PP2C), and RNA-binding proteins such as Rnc1 that feedback on the SAPK pathway [2, 4, 8].
• Dysregulation of SAPK negative regulation is implicated in cancer, cardiovascular disease, neurodegeneration, and metabolic disorders [3, 5, 6].
• CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the causal roles of negative regulators in SAPK signaling [5, 8].
• EDITGENE provides custom cell models and CRISPR library screening to study GO:0070303-related genes in disease and drug discovery.
Description
The stress-activated protein kinase (SAPK) signaling cascade, comprising the JNK and p38 MAPK pathways, is a central mediator of cellular responses to environmental stress, inflammatory cytokines, and apoptotic stimuli [1, 7]. Unchecked SAPK signaling can lead to excessive apoptosis, chronic inflammation, and tissue damage, making its negative regulation a critical homeostatic mechanism [3, 5]. GO:0070303, negative regulation of stress-activated protein kinase signaling cascade, encompasses all processes that attenuate or terminate SAPK signaling, ensuring appropriate cellular outcomes [2, 4]. Researchers study this term to understand how cells balance survival and death decisions, and to identify therapeutic targets for diseases driven by aberrant stress signaling [6, 8]. This article integrates authoritative GO annotation with published literature to provide a comprehensive overview of the mechanisms, key regulators, and experimental approaches for investigating GO:0070303.
negative regulation of stress-activated protein kinase signaling cascade At A Glance
| GO ID | GO:0070303 |
|---|---|
| GO term | negative regulation of stress-activated protein kinase signaling cascade |
| Ontology | biological_process |
| Synonym | inhibition of stress-activated protein kinase signaling pathway; negative regulation of SAPK signaling pathway; downregulation of stress-activated protein kinase signaling pathway |
| Major function | Attenuation or termination of JNK and p38 MAPK signaling in response to stress, cytokines, and apoptotic stimuli |
| Key regulators | MAPK phosphatases (MKP-1/DUSP1), PP2C, Rnc1, and other feedback inhibitors [2, 4, 8] |
| Associated diseases | Cancer, cardiovascular disease, Alzheimer's disease, inflammatory disorders [3, 5, 6] |
| Research methods | CRISPR knockout/knock-in, phospho-proteomics, RNA-seq, kinase activity assays [5, 8] |
What Is GO:0070303?
GO:0070303 is defined as any process that stops, prevents, or reduces the frequency, rate or extent of signaling via the stress-activated protein kinase signaling cascade. In practice, this includes the action of phosphatases that dephosphorylate SAPKs, feedback inhibitors that downregulate upstream kinases, and RNA-binding proteins that modulate pathway components, ultimately dampening JNK and p38 MAPK activity [2, 4, 8].
Why Is negative regulation of stress-activated protein kinase signaling cascade Important in Cell Biology?
Negative regulation of SAPK signaling is vital for maintaining cellular homeostasis and preventing pathological outcomes such as chronic inflammation, neurodegeneration, and tumor progression [3, 5, 6]. Understanding GO:0070303 provides insights into how cells resolve stress responses and offers therapeutic opportunities to modulate SAPK activity in disease [2, 8].
• Prevents excessive apoptosis and tissue damage by terminating stress-induced JNK/p38 signaling.
• Controls inflammatory responses by limiting cytokine production and immune cell activation.
• Regulates cell growth and proliferation via cross-talk with TORC1 and other growth pathways.
• Dysregulation contributes to cancer chemoresistance and metastasis.
• Implicated in cardiovascular diseases such as atherosclerosis and hypertension [2, 3].
• Plays a role in neurodegenerative conditions like Alzheimer's disease through astrocyte immunoregulation.
• Essential for proper stress adaptation in model organisms like fission yeast.
• Provides targets for anti-inflammatory and anticancer drug development.
• Helps explain individual variability in stress responses and disease susceptibility.
• Enables precision medicine approaches by identifying patient-specific signaling defects.
What Happens During negative regulation of stress-activated protein kinase signaling cascade?
Initiation of SAPK signaling and the need for negative regulation
In simple terms: When cells face stress, a signaling chain called SAPK gets switched on, but it must be turned off later to avoid harm.
Stress stimuli such as UV radiation, inflammatory cytokines, and ceramide activate the SAPK cascade, leading to JNK and p38 MAPK phosphorylation and activation [1, 7]. This activation triggers downstream responses including apoptosis, cytokine production, and growth arrest. To prevent excessive or prolonged signaling, cells employ negative regulatory mechanisms that are captured by GO:0070303 [2, 4].
Dephosphorylation by MAPK phosphatases
In simple terms: Special enzymes called phosphatases remove phosphate groups from SAPK proteins, switching them off.
MAPK phosphatase-1 (MKP-1/DUSP1) is a key negative regulator that dephosphorylates JNK and p38, thereby terminating SAPK signaling. In vascular smooth muscle cells, MKP-1 expression is regulated by angiotensin II and other stimuli, highlighting its role in cardiovascular stress responses. Similarly, protein phosphatase 2C (PP2C) negatively regulates the TAK1 signaling pathway, which lies upstream of SAPK activation.
Feedback inhibition by RNA-binding proteins
In simple terms: Some RNA-binding proteins act as brakes on the SAPK pathway by destabilizing or modulating pathway components.
In fission yeast, the RNA-binding protein Rnc1 negatively regulates the stress-activated MAPK pathway through a negative feedback loop, affecting cell length at division and acute stress response. This illustrates an evolutionarily conserved mechanism where RNA-binding proteins fine-tune SAPK signaling output.
Cross-talk with other signaling pathways
In simple terms: The SAPK off-switch is connected to other cellular signals, so turning it off can affect growth and metabolism.
Negative regulation of SAPK signaling intersects with the TORC1 pathway, as p38 SAPK activity modulates cell growth via TORC1. Additionally, sodium-dependent signal transduction can regulate the JNK/SAPK cascade, indicating that ion homeostasis influences SAPK negative regulation. These cross-talks ensure that stress responses are coordinated with growth and metabolic cues.
Role in apoptosis and cell fate decisions
In simple terms: Turning off SAPK can decide whether a cell lives or dies under stress.
Ceramide and sphingosine coordinately regulate stress- and mitogen-activated protein kinases during apoptosis, and negative regulation of SAPK can shift the balance toward survival. Inhibition of p38 SAPK induces low-density lipoprotein receptor expression, linking SAPK negative regulation to lipid metabolism and cell survival. Thus, GO:0070303 is central to cell fate decisions under stress [3, 7].
Key Genes Involved in GO:0070303 negative regulation of stress-activated protein kinase signaling cascade
The following genes and proteins are experimentally validated participants in the negative regulation of stress-activated protein kinase signaling cascade (GO:0070303).
| Gene | Major Role | Research Relevance |
|---|---|---|
| DUSP1 (MKP-1) | Dephosphorylates JNK and p38, terminating SAPK signaling | Cardiovascular disease, inflammation, cancer |
| PPM1A/B (PP2C) | Negatively regulates TAK1 upstream of SAPK | Inflammatory signaling, immune disorders |
| RNC1 | RNA-binding protein that feedback-inhibits SAPK pathway in fission yeast | Stress response, cell cycle regulation |
| JNK1/2/3 | Core SAPK kinases whose activity is attenuated by negative regulators [1, 7] | Apoptosis, neurodegeneration, cancer |
| p38 MAPK (MAPK14) | Stress-activated kinase targeted by negative regulators [3, 5] | Inflammation, metabolic disease, cancer |
| TAK1 (MAP3K7) | Upstream kinase in SAPK cascade regulated by PP2C | Immune signaling, cancer |
| PKC-eta | Immunoregulatory kinase in astrocytes, linked to SAPK modulation | Alzheimer's disease, neuroinflammation |
| TORC1 | Growth regulator influenced by p38 SAPK activity | Cell growth, metabolism, cancer |
| LDLR | Expression induced by p38 SAPK inhibition | Lipid metabolism, atherosclerosis |
| Ceramide/sphingosine | Lipids that regulate SAPK and MAPK during apoptosis | Apoptosis, cancer therapy |
| Sodium-dependent transporters | Regulate JNK/SAPK cascade via ion homeostasis | Hypertension, ion transport disorders |
| MKP family (DUSP2, DUSP4, DUSP6) | Additional phosphatases with potential SAPK regulatory roles | Cancer, inflammation |
| ASK1 (MAP3K5) | Upstream MAP3K in SAPK cascade, subject to negative regulation | Oxidative stress, neurodegeneration |
| MKK4/7 | Direct activators of JNK, targets of negative feedback | Stress response, cancer |
| MKK3/6 | Direct activators of p38, targets of negative feedback | Inflammation, cancer |
| Rnc1 homologs (human) | Potential RNA-binding regulators of SAPK in higher eukaryotes | Stress adaptation, RNA biology |
| DUSP10 (MKP-5) | Phosphatase that preferentially inactivates p38 and JNK | Inflammation, cancer |
How Is negative regulation of stress-activated protein kinase signaling cascade Regulated?
Negative regulation of SAPK signaling is itself tightly regulated. MKP-1 expression is induced by stress and hormones such as angiotensin II, creating a negative feedback loop. PP2C activity toward TAK1 is modulated by cellular conditions. In fission yeast, Rnc1 provides feedback inhibition that adjusts SAPK output according to cell cycle and stress status. Cross-talk with TORC1 links SAPK negative regulation to nutrient and growth signals. Additionally, sodium-dependent pathways can influence JNK/SAPK cascade activity, suggesting ion homeostasis as a regulatory layer.
negative regulation of stress-activated protein kinase signaling cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DUSP1 (MKP-1) | Cancer, cardiovascular disease | Knockout and overexpression in cancer cell lines; phospho-JNK/p38 readouts |
| PPM1A/B (PP2C) | Inflammatory disorders | Knockout in macrophages; TAK1 phosphorylation assays |
| PKC-eta | Alzheimer's disease | Knockout in primary astrocytes; immunoregulatory assays |
| p38 MAPK (MAPK14) | Metabolic disease, cancer | Point mutation (kinase-dead) knock-in; TORC1 activity assays |
| RNC1 | Stress response (fission yeast model) | Knockout and tagged knock-in in S. pombe; cell length and stress assays |
Cancer and chemoresistance
Dysregulated SAPK signaling contributes to tumor progression and resistance to chemotherapy. Negative regulators such as MKP-1 are often overexpressed in cancers, leading to reduced JNK/p38 activity and enhanced survival. Conversely, loss of negative regulation can promote apoptosis, making these pathways attractive for therapeutic intervention [3, 5].
Cardiovascular disease
In vascular smooth muscle cells, MKP-1 is regulated by angiotensin II and modulates SAPK activity, influencing vascular remodeling and hypertension. Inhibition of p38 SAPK induces LDL receptor expression, linking SAPK negative regulation to cholesterol metabolism and atherosclerosis.
Neurodegeneration and Alzheimer's disease
Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model and exhibits immunoregulatory functions that may intersect with SAPK negative regulation. Chronic SAPK activation in neurons contributes to neurodegeneration, and enhancing negative regulation could be protective [6, 7].
Inflammatory and metabolic disorders
Negative regulation of SAPK signaling limits inflammatory cytokine production and immune cell activation [4, 6]. PP2C-mediated inhibition of TAK1 dampens inflammatory signaling, and its dysregulation is linked to autoimmune and metabolic diseases. p38 SAPK inhibition also affects TORC1 and cell growth, implicating GO:0070303 in metabolic regulation.
From negative regulation of stress-activated protein kinase signaling cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DUSP1 enhance SAPK signaling? | DUSP1 knockout cell line with phospho-JNK/p38 Western blot |
| Can a point mutation in p38 prevent negative regulation? | Knock-in of phospho-acceptor mutant p38 |
| How does PP2C regulate TAK1 in inflammation? | PP2C knockout macrophages with TAK1 activity assays |
| What is the role of Rnc1 in stress response? | Rnc1 knockout and tagged knock-in in fission yeast |
| Does PKC-eta modulate SAPK in astrocytes? | PKC-eta knockout primary astrocytes with cytokine profiling |
| Can overexpression of MKP-1 protect against apoptosis? | DUSP1 overexpression in neuronal cell lines with ceramide treatment |
How to Study the negative regulation of stress-activated protein kinase signaling cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot (phospho-JNK/p38) | Activation status of SAPK | Validation of negative regulator knockout |
| Kinase activity assay | Enzymatic activity of JNK/p38 | Direct assessment of phosphatase effects |
| CRISPR knockout screen | Genes whose loss alters SAPK signaling | Discovery of novel negative regulators |
| RNA-seq | Transcriptional changes upon SAPK modulation | Pathway analysis in disease models |
| FRET biosensor imaging | Real-time SAPK activity dynamics | Live-cell kinetics of negative regulation |
| Co-immunoprecipitation | Protein-protein interactions | Identifying phosphatase-substrate complexes |
| Mass spectrometry phosphoproteomics | Global phosphorylation changes | Mapping SAPK substrate networks |
| Yeast genetics (S. pombe) | Stress response and cell morphology | Functional studies of Rnc1 and homologs |
Phospho-proteomics and kinase activity assays
Quantifying phosphorylation of JNK and p38 by Western blot or mass spectrometry is the gold standard for assessing SAPK activity and the impact of negative regulators [1, 2, 5]. Kinase activity assays using recombinant substrates provide direct enzymatic readouts.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify novel negative regulators of SAPK signaling. Cells are challenged with stress (e.g., UV, ceramide) and sgRNA enrichment is measured by sequencing [5, 8].
Transcriptomics and RNA-seq
RNA-seq after perturbation of candidate negative regulators reveals downstream transcriptional programs, including inflammatory cytokines and stress-response genes [6, 8].
Live-cell imaging and biosensors
FRET-based or luciferase reporters of JNK/p38 activity enable real-time monitoring of SAPK dynamics and the kinetics of negative regulation in living cells [5, 7].
How CRISPR Can Be Used to Study GO:0070303 negative regulation of stress-activated protein kinase signaling cascade
Knockout
CRISPR knockout of negative regulators such as DUSP1 or PPM1A leads to hyperactivation of SAPK signaling, providing causal evidence for their role in GO:0070303 [2, 4]. Knockout cell lines are essential for validating gene function in disease models.
Point Mutation
Introducing point mutations in catalytic residues of phosphatases (e.g., DUSP1) or phospho-acceptor sites in p38/JNK allows precise dissection of negative regulation mechanisms without complete gene loss.
Knock-in
Tagged knock-in of SAPK components (e.g., GFP-p38) enables real-time imaging and proteomic analysis of negative regulation dynamics in live cells.
Overexpression
Overexpression of negative regulators like MKP-1 can suppress SAPK signaling and protect against stress-induced apoptosis, offering a gain-of-function approach to study GO:0070303 [2, 7].
How EDITGENE Supports negative regulation of stress-activated protein kinase signaling cascade Research
Researchers studying negative regulation of stress-activated protein kinase signaling cascade-related genes often need to determine whether a candidate gene is causally involved in dampening SAPK signaling, and to define the precise molecular mechanism. EDITGENE provides end-to-end CRISPR services to generate validated cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of stress-activated protein kinase signaling cascade research.
Frequently Asked Questions About negative regulation of stress-activated protein kinase signaling cascade
What is GO:0070303?
GO:0070303 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate or extent of signaling via the stress-activated protein kinase signaling cascade [2, 4].
What genes are involved in negative regulation of stress-activated protein kinase signaling cascade?
Key genes include DUSP1 (MKP-1), PPM1A/B (PP2C), RNC1, and other phosphatases and RNA-binding proteins that attenuate JNK and p38 MAPK signaling [2, 4, 8].
How is SAPK signaling negatively regulated?
Negative regulation occurs through dephosphorylation by MAPK phosphatases, feedback inhibition by RNA-binding proteins, and cross-talk with pathways like TORC1 [2, 4, 5, 8].
Why is negative regulation of SAPK signaling important?
It prevents excessive apoptosis, inflammation, and growth arrest, and its dysregulation is linked to cancer, cardiovascular disease, and neurodegeneration [3, 5, 6].
What diseases are associated with defective SAPK negative regulation?
Cancer, atherosclerosis, Alzheimer's disease, and inflammatory disorders have been linked to altered negative regulation of SAPK signaling [2, 3, 6].
How can I study GO:0070303 in the lab?
Common methods include phospho-Western blot, kinase assays, CRISPR knockout/knock-in, RNA-seq, and live-cell imaging [1, 2, 5, 7].
What is the role of MKP-1 in SAPK signaling?
MKP-1 (DUSP1) is a phosphatase that dephosphorylates JNK and p38, thereby terminating SAPK signaling and acting as a key negative regulator.
Can CRISPR be used to study negative regulation of SAPK signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the function of negative regulators in SAPK signaling [5, 8].
What is the connection between SAPK negative regulation and TORC1?
p38 SAPK activity modulates TORC1, linking negative regulation of SAPK to cell growth control.
How does Rnc1 regulate the SAPK pathway?
Rnc1 is an RNA-binding protein that provides negative feedback on the stress-activated MAPK pathway in fission yeast, influencing cell length and stress response.
Conclusion
GO:0070303, negative regulation of stress-activated protein kinase signaling cascade, is a critical biological process that safeguards cells against excessive stress signaling. Through phosphatases, RNA-binding proteins, and pathway cross-talk, cells tightly control JNK and p38 MAPK activity to balance survival and death. Understanding this process offers insights into cancer, cardiovascular disease, and neurodegeneration, and provides a rich source of therapeutic targets. EDITGENE's CRISPR services empower researchers to functionally validate these regulators and accelerate discovery.
References
- 1. Kuroki DW et al.. 1997. Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway.. J Biol Chem 272(38):23905-11 PMID: 9295340
- 2. Bokemeyer D et al.. 1998. Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells.. Hypertension 32(4):661-7 PMID: 9774360
- 3. Mehta KD et al.. 1999. Inhibition of stress-activated p38 mitogen-activated protein kinase induces low-density lipoprotein receptor expression.. Trends Cardiovasc Med 9(7):201-5 PMID: 10881752
- 4. Hanada M et al.. 2001. Regulation of the TAK1 signaling pathway by protein phosphatase 2C.. J Biol Chem 276(8):5753-9 PMID: 11104763
- 5. Cully M et al.. 2010. A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1.. Mol Cell Biol 30(2):481-95 PMID: 19917724
- 6. Muraleedharan A et al.. 2021. Protein kinase C eta is activated in reactive astrocytes of an Alzheimer's disease mouse model: Evidence for its immunoregulatory function in primary astrocytes.. Glia 69(3):697-714 PMID: 33068318
- 7. Jarvis WD et al.. 1997. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine.. Mol Pharmacol 52(6):935-47 PMID: 9415703
- 8. Prieto-Ruiz F et al.. 2020. RNA-Binding Protein Rnc1 Regulates Cell Length at Division and Acute Stress Response in Fission Yeast through Negative Feedback Modulation of the Stress-Activated Mitogen-Activated Protein Kinase Pathway.. mBio 11(1) PMID: 31911490
